关注
Gabriele Cavalieri
Gabriele Cavalieri
PhD student in Nanotechnology, University of Trieste
在 phd.units.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Binding of the B-Raf inhibitors dabrafenib and vemurafenib to human serum albumin: a biophysical and molecular simulation study
M Russi, G Cavalieri, D Marson, E Laurini, S Pricl
Molecular Pharmaceutics 19 (5), 1619-1634, 2022
132022
Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin
G Cavalieri, G Cilurzo, L Pettorosso, A Mansueto, E Laurini, S Pricl
European Journal of Pharmaceutical Sciences 189, 106550, 2023
52023
Molecular Ballet: Investigating the Complex Interaction between Self-Assembling Dendrimers and Human Serum Albumin via Computational and Experimental Methods
G Cavalieri, D Marson, N Giurgevich, R Valeri, F Felluga, E Laurini, S Pricl
Pharmaceutics 16 (4), 533, 2024
22024
Into the Groove: A Multitechnique Insight into the DNA–Vemurafenib Interaction
G Cavalieri, R Pison, D Marson, E Laurini, S Pricl
Applied Biosciences 3 (4), 468-483, 2024
2024
361 (PB349): Dendrimers in cancer therapy: exploring protein corona interactions for enhanced drug delivery and theragnostic applications
G Cavalieri, E Laurini, D Marson, S Pricl
European Journal of Cancer 211, 114874, 2024
2024
Beyond the Veil: Free Energy Profiles and Partition Coefficients for Antimelanoma Drugs in Self-Assembled Nanomicelles via COSMOmic and Atomistic Molecular Dynamics Simulations
A Mio, D Marson, G Cavalieri, M Fermeglia, E Laurini, S Pricl
Journal of Chemical & Engineering Data, 2024
2024
Rare BRAF mutations in menlanoma and beyond: Rationalizing the afficacy of B-raf inhibitors via HPC-based in silico/in vitro investigations
S Pricl, E Laurini, D Marson, G Cavalieri
MOLECULAR CANCER THERAPEUTICS 22 (12), 2023
2023
Abstract C153: Rare BRAF mutations in menlanoma and beyond: Rationalizing the afficacy of B-raf inhibitors via HPC-based in silico/in vitro investigations
S Pricl, E Laurini, D Marson, G Cavalieri
Molecular Cancer Therapeutics 22 (12_Supplement), C153-C153, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–8